![Stem cell markers (cytokeratin 15, cytokeratin 19 and p63) in in situ and invasive cutaneous epithelial lesions | Modern Pathology Stem cell markers (cytokeratin 15, cytokeratin 19 and p63) in in situ and invasive cutaneous epithelial lesions | Modern Pathology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fmodpathol.2010.180/MediaObjects/41379_2011_Article_BFmodpathol2010180_Fig1_HTML.jpg)
Stem cell markers (cytokeratin 15, cytokeratin 19 and p63) in in situ and invasive cutaneous epithelial lesions | Modern Pathology
![A combination of cytokeratin 5/6, p63, p40 and MUC5AC are useful for distinguishing squamous cell carcinoma from adenocarcinoma of the cervix | Diagnostic Pathology | Full Text A combination of cytokeratin 5/6, p63, p40 and MUC5AC are useful for distinguishing squamous cell carcinoma from adenocarcinoma of the cervix | Diagnostic Pathology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13000-020-01018-7/MediaObjects/13000_2020_1018_Fig1_HTML.png)
A combination of cytokeratin 5/6, p63, p40 and MUC5AC are useful for distinguishing squamous cell carcinoma from adenocarcinoma of the cervix | Diagnostic Pathology | Full Text
![Cytoplasmic p63 immunohistochemistry is a useful marker for muscle differentiation: an immunohistochemical and immunoelectron microscopic study | Modern Pathology Cytoplasmic p63 immunohistochemistry is a useful marker for muscle differentiation: an immunohistochemical and immunoelectron microscopic study | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fmodpathol.2011.89/MediaObjects/41379_2011_Article_BFmodpathol201189_Fig1_HTML.jpg)
Cytoplasmic p63 immunohistochemistry is a useful marker for muscle differentiation: an immunohistochemical and immunoelectron microscopic study | Modern Pathology
![Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer - ScienceDirect Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1092913420301805-ga1.jpg)
Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer - ScienceDirect
![Presentation of SOX10, p63, and myoepithelial marker distribution in... | Download Scientific Diagram Presentation of SOX10, p63, and myoepithelial marker distribution in... | Download Scientific Diagram](https://www.researchgate.net/publication/236113853/figure/fig3/AS:272049025318931@1441872951084/Presentation-of-SOX10-p63-and-myoepithelial-marker-distribution-in-human-normal.png)
Presentation of SOX10, p63, and myoepithelial marker distribution in... | Download Scientific Diagram
The Use of P63 Immunohistochemistry for the Identification of Squamous Cell Carcinoma of the Lung | PLOS ONE
![Prostate adenocarcinomas aberrantly expressing p63 are molecularly distinct from usual-type prostatic adenocarcinomas | Modern Pathology Prostate adenocarcinomas aberrantly expressing p63 are molecularly distinct from usual-type prostatic adenocarcinomas | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fmodpathol.2014.115/MediaObjects/41379_2015_Article_BFmodpathol2014115_Fig1_HTML.jpg)